SEARCH

SEARCH BY CITATION

References

  • Belcher A. M., O'Dell S. J. and Marshall J. F. (2005) Impaired object recognition memory following methamphetamine, but not p-chloroamphetamine- or d-amphetamine-induced neurotoxicity. Neuropsychopharmacology 30, 20262034.
  • Belcher A. M., Feinstein E. M., O'Dell S. J. and Marshall J. F. (2008) Methamphetamine influences on recognition memory: comparison of escalating and single-day dosing regimens. Neuropsychopharmacology 33, 14531463.
  • Berglund M. M., Hipskind P. A. and Gehlert D. R. (2003) Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes. Exp. Biol. Med. 228, 217244.
  • Bliss T. V. and Collingridge G. L. (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 3139.
  • Broadbent N. J., Squire L. R. and Clark R. E. (2004) Spatial memory, recognition memory, and the hippocampus. Proc. Natl Acad. Sci. USA 101, 1451514520.
  • Bruel-Jungerman E., Davis S. and Laroche S. (2007) Brain plasticity mechanisms and memory: a party of four. Neuroscientist 13, 492505.
  • Bura S. A., Castañé A., Ledent C., Valverde O. and Maldonado R. (2007) Genetic and pharmacological approaches to evaluate the interaction between the cannabinoid and cholinergic systems in cognitive processes. Br. J. Pharmacol. 150, 758765.
  • Cadet J. L. and Krasnova I. N. (2009) Molecular bases of methamphetamine-induced neurodegeneration. Int. Rev. Neurobiol. 88, 101119.
  • Cammalleri M., Lütjens R., Berton F., King A. R., Simpson C., Francesconi W. and Sanna P. P. (2003) Time-restricted role for dendritic activation of the mTOR-p70S6K pathway in the induction of late-phase long-term potentiation in the CA1. Proc. Natl Acad. Sci. USA 100, 1436814373.
  • Cannizzarro C., Tel B. C., Rose S., Zeng B. Y. and Jenner P. (2003) Increased neuropeptide Y mRNA expression in striatum in Parkinson's disease. Brain Res. Mol. Brain Res. 110, 169176.
  • Chen W. S., Xu P. Z., Gottlob K. et al. (2001) Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev. 15, 22032208.
  • Cherng C. G., Tsai C. W., Tsai Y. P., Ho M. C., Kao S. F. and Yu L. (2007) Methamphetamine-disrupted sensory processing mediates conditioned place preference performance. Behav. Brain Res. 182, 103108.
  • Christensen D. Z., Olesen M. V., Kristiansen H., Mikkelsen J. D. and Woldbye D. P. (2006) Unaltered neuropeptide Y (NPY)-stimulated [35S]GTPgammaS binding suggests a net increase in NPY signalling after repeated electroconvulsive seizures in mice. J. Neurosci. Res. 84, 12821291.
  • Cook C. E., Jeffcoat A. R., Hill J. M., Pugh D. E., Patetta P. K., Sadler B. M., White W. R. and Perez-Reyes M. (1993) Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride. Drug Metab. Dispos. 21, 717723.
  • Costa-Mattioli M., Sossin W. S., Klann E. and Sonenberg N. (2009) Translational control of long-lasting synaptic plasticity and memory. Neuron 61, 1026.
  • Decressac M., Wright B., David B., Tyers P., Jaber M., Barker R. A. and Gaillard A. (2010) Exogenous neuropeptide Y promotes in vivo hippocampal neurogenesis. Hippocampus 21, 233238.
  • Dumont Y., Cadieux A., Doods H., Pheng L. H., Abounader R., Hamel E., Jacques D., Regoli D. and Quirion R. (2000) BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist. Br. J. Pharmacol. 129, 10751088.
  • Duszczyk M., Ziembowicz A., Gadamski R., Wieronska J. M., Smialowska M. and Lazarewicz J. W. (2009) Changes in the NPY immunoreactivity in gerbil hippocampus after hypoxia and ischemic preconditioning. Neuropeptides 43, 3139.
  • Easton R. M., Cho H., Roovers K. et al. (2005) Role for Akt3/protein kinase Bgamma in attainment of normal brain size. Mol. Cell. Biol. 25, 18691878.
  • Frankland P. W. and Bontempi B. (2005) The organization of recent and remote memories. Nat. Rev. Neurosci. 6, 119130.
  • Gehlert D. R. (2004) Introduction to the reviews on neuropeptide Y. Neuropeptides 38, 135140.
  • Gonçalves J., Martins T., Ferreira R., Milhazes N., Borges F., Ribeiro C. F., Malva J. O., Macedo T. R. and Silva A. P. (2008) Methamphetamine-induced early increase of IL-6 and TNF-alpha mRNA expression in the mouse brain. Ann. N. Y. Acad. Sci. 1139, 103111.
  • Gonçalves J., Baptista S., Martins T., Milhazes N., Borges F., Ribeiro C. F., Malva J. O. and Silva A. P. (2010) Methamphetamine-induced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin. Eur. J. Neurosci. 31, 315326.
  • Goodman J. H. and Slovitter R. S. (1993) Cocaine neurotoxicity and altered neuropeptide Y immunoreactivity in the rat hippocampus; a silver degeneration and immunocytochemistry study. Brain Res. 616, 263272.
  • Gøtzsche C. R., Nikitidou L., Sørensen A. T., Olesen M. V., Sørensen G., Christiansen S. H., Angehagen M., Woldbye D. P. and Kokaia M. (2012) Combined gene overexpression of neuropeptide Y and its receptor Y5 in the hippocampus suppresses seizures. Neurobiol. Dis. 45, 288296.
  • Hoeffer C. A. and Klann E. (2010) mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci. 33, 6775.
  • Hori N., Kadota M. T., Watanabe M., Ito Y., Akaike N. and Carpenter D. O. (2010) Neurotoxic effects of methamphetamine on rat hippocampus pyramidal neurons. Cell. Mol. Neurobiol. 30, 849856.
  • Horner K. A., Westwood S. C., Hanson G. R. and Keefe K. A. (2006) Multiple high doses of methamphetamine increase the number of preproneuropeptide Y mRNA-expressing neurons in the striatum of rat via a dopamine D1 receptor-dependent mechanism. J. Pharmacol. Exp. Ther. 319, 414421.
  • Kandel E. R. (2001) The molecular biology of memory storage: a dialogue between genes and synapses. Science 294, 10301038.
  • Karl T., Duffy L. and Herzog H. (2008) Behavioural profile of a new mouse model for NPY deficiency. Eur. J. Neurosci. 28, 173180.
  • Krasnova I. N. and Cadet J. L. (2009) Methamphetamine toxicity and messengers of death. Brain Res. Rev. 60, 379407.
  • Lee K. W., Kim H. C., Lee S. Y. and Jang C. G. (2011) Methamphetamine-sensitized mice are accompanied by memory impairment and reduction of N-methyl-d-aspartate receptor ligand binding in the prefrontal cortex and hippocampus. Neuroscience 178, 101107.
  • Marshall J. F. and O'Dell S. J. (2012) Methamphetamine influences on brain and behavior: unsafe at any speed? Trends Neurosci. 35, 536545.
  • Martins T., Baptista S., Gonçalves J. et al. (2011) Methamphetamine transiently increases the blood–brain barrier permeability in the hippocampus: Role of tight junction proteins and matrix metalloproteinase-9. Brain Res. 1411, 2840.
  • Meurs A., Clinckers R., Ebinger G., Michotte Y. and Smolders I. (2007) Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y. Eur. J. Neurosci. 26, 30793092.
  • Naveilhan P., Neveu I., Arenas E. and Ernfors P. (1998) Complementary and overlapping expression of Y1, Y2 and Y5 receptors in the developing and adult mouse nervous system. Neuroscience 87, 289302.
  • Neves G., Cooke S. F. and Bliss T. V. (2008) Synaptic plasticity, memory and the hippocampus: a neural network approach to causality. Nat. Rev. Neurosci. 9, 6575.
  • O'Dell S. J., Feinberg L. M. and Marshall J. F. (2011) A neurotoxic regimen of methamphetamine impairs novelty recognition as measured by a social odor-based task. Behav. Brain Res. 216, 396401.
  • Olesen M. V., Christiansen S. H., Gøtzsche C. R., Nikitidou L., Kokaia M. and Woldbye D. P. (2012) Neuropeptide Y Y1 receptor hippocampal overexpression via viral vectors is associated with modest anxiolytic-like and proconvulsant effects in mice. J. Neurosci. Res. 90, 498507.
  • Olling J. D., Ulrichsen J., Christensen D. Z. and Woldbye D. P. (2009) Complex plastic changes in the neuropeptide Y system during ethanol intoxication and withdrawal in the rat brain. J. Neurosci. Res. 87, 23862397.
  • Opazo P., Watabe A. M., Grant S. G. and O'Dell T. J. (2003) Phosphatidylinositol 3-kinase regulates the induction of long-term potentiation through extracellular signal-related kinase-independent mechanisms. J. Neurosci. 23, 36793688.
  • Paxinos G. and Franklin K. B. J. (2004) The Mouse Brain in Stereotaxic Coordinates: Compact Second Edition. San Diego, CA, Elsevier Academic Press.
  • Raudensky J. and Yamamoto B. K. (2007) Effects of chronic unpredictable stress and methamphetamine on hippocampal glutamate function. Brain Res. 1135, 129135.
  • Redrobe J. P., Dumont Y., Fournier A. and Quirion R. (2002) The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test. Neuropsychopharmacology 26, 615624.
  • Reichel C. M., Schwendt M., McGinty J. F., Olive M. F. and See R. E. (2011) Loss of object recognition memory produced by extended access to methamphetamine self-administration is reversed by positive allosteric modulation of metabotropic glutamate receptor 5. Neuropsychopharmacology 36, 782792.
  • Reichel C. M., Ramsey L. A., Schwendt M., McGinty J. F. and See R. E. (2012) Methamphetamine-induced changes in the object recognition memory circuit. Neuropharmacology 62, 11191126.
  • Rimondini R., Thorsell A. and Heilig M. (2005) Suppression of ethanol self-administration by the neuropeptide Y (NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence. Neurosci. Lett. 375, 129133.
  • Salo R., Ursu S., Buonocore M. H., Leamon M. H. and Carter C. (2009) Impaired prefrontal cortical function and disrupted adaptive cognitive control in methamphetamine abusers: a functional magnetic resonance imaging study. Biol. Psychiatry 65, 706709.
  • Schroeder J. P., Iller K. A. and Hodge C. W. (2003) Neuropeptide-Y Y5 receptors modulate the onset and maintenance of operant ethanol self-administration. Alcohol. Clin. Exp. Res. 27, 19121920.
  • Schwarzer C. and Sperk G. (1998) Glutamate-stimulated neuropeptide Y mRNA expression in the rat dentate gyrus: a prominent role of metabotropic glutamate receptors. Hippocampus 8, 274288.
  • Scott J. C., Woods S. P., Matt G. E., Meyer R. A., Heaton R. K., Atkinson J. H. and Grant I. (2007) Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol. Rev. 17, 275297.
  • Silva A. P., Carvalho A. P., Carvalho C. M. and Malva J. O. (2001) Modulation of intracellular calcium changes and glutamate release by neuropeptide Y1 and Y2 receptors in the rat hippocampus: differential effects in CA1, CA3 and dentate gyrus. J. Neurochem. 79, 286296.
  • Silva A. P., Pinheiro P. S., Carvalho A. P., Carvalho C. M., Jakobsen B., Zimmer J. and Malva J. O. (2003a) Activation of neuropeptide Y receptors is neuroprotective against excitotoxicity in organotypic hippocampal slice cultures. FASEB J. 17, 11181120.
  • Silva A. P., Carvalho A. P., Carvalho C. M. and Malva J. O. (2003b) Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus. Neuropharmacology 44, 282292.
  • Silva A. P., Xapelli S., Pinheiro P. S., Ferreira R., Lourenço J., Cristovão A., Grouzmann E., Cavadas C., Oliveira C. R. and Malva J. O. (2005a) Up-regulation of neuropeptide Y levels and modulation of glutamate release through neuropeptide Y receptors in the hippocampus of kainate-induced epileptic rats. J. Neurochem. 93, 163170.
  • Silva A. P., Xapelli S., Grouzmann E. and Cavadas C. (2005b) The putative neuroprotective role of neuropeptide Y in the central nervous system. Curr. Drug Targets CNS Neurol. Disord. 4, 331347.
  • Silva A. P., Lourenço J., Xapelli S., Ferreira R., Kristiansen H., Woldbye D. P., Oliveira C. R. and Malva J. O. (2007) Protein kinase C activity blocks neuropeptide Y-mediated inhibition of glutamate release and contributes to excitability of the hippocampus in status epilepticus. FASEB J. 21, 671681.
  • Silva A. P., Martins T., Baptista S., Gonçalves J., Agasse F. and Malva J. O. (2010) Brain injury associated with widely abused amphetamines: neuroinflammation, neurogenesis and blood–brain barrier. Curr. Drug Abuse Rev. 3, 239254.
  • Simões P. F., Silva A. P., Pereira F. C., Marques E., Grade S., Milhazes N., Borges F., Ribeiro C. F. and Macedo T. R. (2007) Methamphetamine induces alterations on hippocampal NMDA and AMPA receptor subunit levels and impairs spatial working memory. Neuroscience 150, 433441.
  • Sørensen A. T., Kanter-Schlifke I., Carli M., Balducci C., Noe F., During M. J., Vezzani A. and Kokaia M. (2008a) NPY gene transfer in the hippocampus attenuates synaptic plasticity and learning. Hippocampus 18, 564574.
  • Sørensen A. T., Kanter-Schlifke I., Lin E. J., During M. J. and Kokaia M. (2008b) Activity-dependent volume transmission by transgene NPY attenuates glutamate release and LTP in the subiculum. Mol. Cell. Neurosci. 39, 229237.
  • Sóvágó J., Dupuis D. S., Gulyás B. and Hall H. (2001) An overview on functional receptor autoradiography using [35S]GTPgammaS. Brain Res. Brain Res. Rev. 38, 149164.
  • Swant J., Chirwa S., Stanwood G. and Khoshbouei H. (2010) Methamphetamine reduces LTP and increases baseline synaptic transmission in the CA1 region of mouse hippocampus. PLoS ONE 5, e11382.
  • Takahashi H., Kato M., Takano H. et al. (2008) Differential contributions of prefrontal and hippocampal dopamine D(1) and D(2) receptors in human cognitive functions. J. Neurosci. 28, 1203212038.
  • Thiele T. E., Koh M. T. and Pedrazzini T. (2002) Voluntary alcohol consumption is controlled via the neuropeptide Y Y1 receptor. J. Neurosci. 2, RC208.
  • Thiriet N., Deng X., Solinas M., Ladenheim B., Curtis W., Goldberg S. R., Palmiter R. D. and Cadet J. L. (2005) Neuropeptide Y protects against methamphetamine-induced neuronal apoptosis in the mouse striatum. J. Neurosci. 25, 52735279.
  • Thompson P. M., Hayashi K. M., Simon S. L., Geaga J. A., Hong M. S., Sui Y., Lee J. Y., Toga A. W., Ling W. and London E. D. (2004) Structural abnormalities in the brains of human subjects who use methamphetamine. J. Neurosci. 24, 60286036.
  • Thorsell A., Michalkiewicz M., Dumont Y., Quirion R., Caberlotto L. and Rimondini R. (2000) Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc. Natl Acad. Sci. USA 97, 1285212857.
  • Thorsell A., Rimondini R. and Heilig M. (2002) Blockade of central neuropeptide Y (NPY) Y2 receptors reduces ethanol self-administration in rats. Neurosci. Lett. 332, 14.
  • Tulloch I. K., Afanador L., Zhu J. and Angulo J. A. (2011) Methamphetamine induces striatal cell death followed by the generation of new cells and a second round of cell death in mice. Curr. Neuropharmacol. 9, 7983.
  • Vann S. D. and Albasser M. M. (2011) Hippocampus and neocortex: recognition and spatial memory. Curr. Opin. Neurobiol. 21, 440445.
  • Vezzani A. and Sperk G. (2004) Overexpression of NPY and Y2 receptors in epileptic brain tissue: an endogenous neuroprotective mechanism in temporal lobe epilepsy? Neuropeptides 38, 245252.
  • Wiltgen B. J., Zhou M., Cai Y., Balaij J., Karlsson M. G., Parivash S. N., Li W. and Silva A. J. (2010) The hippocampus plays a selective role in the retrieval of detailed contextual memories. Curr. Biol. 20, 13361344.
  • Woldbye D. P., Madsen T. M., Larsen P. J., Mikkelsen J. D. and Bolwig T. G. (1996) Neuropeptide Y inhibits hippocampal seizures and wet dog shakes. Brain Res. 737, 162168.
  • Woldbye D. P., Nanobashvili A., Sørensen A. T., Husum H., Bolwig T. G., Sørensen G., Ernfors P. and Kokaia M. (2005) Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors. Neurobiol. Dis. 20, 760772.
  • Woldbye D. P., Angehagen M., Gøtzsche C. R. et al. (2010) Adeno-associated viral vector-induced overexpression of neuropeptide Y Y2 receptors in the hippocampus suppresses seizures. Brain 133, 27782788.
  • Woulfe D., Jiang H., Morgans A., Monks R., Birnbaum M. and Brass L. F. (2004) Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2. J. Clin. Invest. 113, 441450.
  • Xapelli S., Agasse F., Ferreira R., Silva A. P. and Malva J. O. (2006) Neuropeptide Y as an endogenous antiepileptic, neuroprotective and pro-neurogenic peptide. Recent Pat. CNS Drug Discov. 1, 315324.
  • Xapelli S., Silva A. P., Ferreira R. and Malva J. O. (2007) Neuropeptide Y can rescue neurons from cell death following the application of an excitotoxic insult with kainate in rat organotypic hippocampal slice cultures. Peptides 28, 288294.
  • Zambello E., Zanetti L., Hédou G. F., Angelici O., Arban R., Tasan R. O., Sperk G. and Caberlotto L. (2011) Neuropeptide Y-Y2 receptor knockout mice: influence of genetic background on anxiety-related behaviors. Neuroscience 176, 42030.
  • Zhu J. P., Xu W. and Angulo J. A. (2006) Methamphetamine-induced cell death: selective vulnerability in neuronal subpopulations of the striatum in mice. Neuroscience 140, 607622.